Labenz J, Borkenstein D-P, Müller M, Labenz G
Innere Medizin, Diakonie Klinikum Jung-Stilling Krankenhaus, Wichernstr. 40, 57074, Siegen, Deutschland.
Reflux-Zentrum Siegerland, Burbach, Deutschland.
Internist (Berl). 2020 Dec;61(12):1249-1263. doi: 10.1007/s00108-020-00890-1.
Gastro-oesophageal reflux disease (GORD), a highly prevalent disease, is defined by troublesome symptoms and/or oesophageal lesions caused by reflux of gastric content. A diagnostic gold standard does not exist. A reliable diagnosis may be difficult in individual cases. Patients' history, endoscopic findings and pH-impedance monitoring contribute to the evaluation of gastro-oesophageal reflux and its consequences. High-resolution manometry may add important information on the pathophysiology of the disease and may help to rule out motility disorders as the leading cause of the symptoms. Proton pump inhibitors (PPI) are the drugs of first choice. In patients with insufficient PPI response, optimization of PPI therapy and/or combination with drugs having another mechanism of action are the available options. If PPIs are not sufficiently effective, not tolerated, or not wished antireflux procedures may be offered in specialized centers taking pathophysiological data into account.
胃食管反流病(GORD)是一种高度常见的疾病,其定义为因胃内容物反流导致的令人困扰的症状和/或食管病变。目前不存在诊断金标准。在个别病例中,可靠的诊断可能较为困难。患者病史、内镜检查结果以及pH阻抗监测有助于评估胃食管反流及其后果。高分辨率测压法可能会为该疾病的病理生理学提供重要信息,并有助于排除动力障碍作为症状的主要原因。质子泵抑制剂(PPI)是首选药物。对于PPI反应不足的患者,优化PPI治疗和/或与具有其他作用机制的药物联合使用是可行的选择。如果PPI疗效不佳、无法耐受或患者不希望使用,在考虑病理生理数据的专业中心可提供抗反流手术。